Cancer Chemotherapy and Pharmacology

, Volume 57, Issue 5, pp 624–630

Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE

  • Ketlin V. Pinheiro
  • Vania T. M. Hungria
  • Elisabeth S. Ficker
  • Claudete J. Valduga
  • Carlos H. Mesquita
  • Raul C. Maranhão
Original Article

Abstract

Background: Neoplastic diseases are often associated with low plasma low-density lipoprotein (LDL) cholesterol and diminished LDL clearance due to upregulation in cancer cells of the receptors that internalize the lipoprotein. Thus, it is possible to use LDL or cholesterol-rich microemulsions (LDE) that bind to LDL receptors as carriers of antineoplastic agents to concentrate those drugs into cancer tissues. Our aim was to determine whether LDL cholesterol concentration plus LDE increased clearance occur in lymphomas. Patients and methods: The LDE labeled with [3 H]-cholesteryl oleate was injected into four Hodgkin’s and 12 non-Hodgkin’s lymphoma patients and into 16 healthy control subjects and the LDE plasma residence time (RT) was determined from sequential plasma samples. Two volunteers with relapsed/refractory lymphoma were treated with 300 mg/m2 body surface etoposide associated with LDE in six cycles at 3-week intervals. Results: The LDL cholesterol was lower in lymphoma patients than in controls (94±52 and 115±16 mg/dL, p=0.0362, respectively). The LDE RT was 49% smaller in lymphoma patients than in controls (RT=21.9 and 45.7 h; p=0.0134), with positive correlation between RT and LDL cholesterol. LDE-etoposide showed no considerable toxicity in all cycles in the two treated patients and the disease remained stable during the treatment. Conclusions: Our results suggest that lymphomas overexpress LDL receptors that make room for using LDE as drug-targeting vehicle and that the LDE-etoposide preparation is suitable for patient use.

Keywords

Cholesterol Drug-targeting Etoposide Lipid emulsions Lymphoma treatment Nanoparticles 

References

  1. 1.
    Ades A, Carvalho JP, Graziani SR, Amancio RF, Souen JS, Pinotti JA, Maranhão RC (2001) Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 82(1):84–87CrossRefPubMedGoogle Scholar
  2. 2.
    Alexopoulos CG, Pournaras S, Vaslamatzis M, Avgerinos A, Raptis S (1992) Changes in serum lipids and lipoprotein in cancer patients during chemotherapy. Cancer Chemother Pharmacol 30:412–416CrossRefPubMedGoogle Scholar
  3. 3.
    Blackman JD, Cabana VG, Mazzone T (1993) The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 233(2):201–204PubMedCrossRefGoogle Scholar
  4. 4.
    Brown MS, Goldstein JL (1976) Receptor-mediated control of cholesterol metabolism. Study of human mutants has disclosed how cells regulate a substance that is both vital and lethal. Science 191:150–154PubMedCrossRefGoogle Scholar
  5. 5.
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47PubMedCrossRefGoogle Scholar
  6. 6.
    Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphoma. J Clin Oncol 17:1244–1253PubMedGoogle Scholar
  7. 7.
    Friedewald WT, Levy RI, Fredrickison DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifugue. Clin Chem 18:499–502PubMedGoogle Scholar
  8. 8.
    Ginsburg GS, Small DM, Atkinson D (1982) Microemulsions of phospholipids and cholesterol esters. J Biol Chem 257:8216–8227PubMedGoogle Scholar
  9. 9.
    Gonçalves RP, Hungria VT, Chiattone CS, Pozzi DB, Maranhão RC (2002) Metabolism of chylomicron-like emulsions in patients with Hodgkin’s and with non-Hodgkin’s lymphoma. Leuk Res 27:147–153CrossRefGoogle Scholar
  10. 10.
    Graziani SR, Igreja FA, Hegg R, Meneghetti C, Brandizzi LI, Barboza R, Amâncio RF, Pinotti JA, Maranhão RC (2002) Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol Oncol 85:493–497CrossRefPubMedGoogle Scholar
  11. 11.
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Hematol J 1(1):53–66CrossRefPubMedGoogle Scholar
  12. 12.
    Hirata RD, Hirata MH, Mesquita CH, Cesar TB, Maranhao RC (1999) Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats. Biochim Biophys Acta 1437:3–62Google Scholar
  13. 13.
    Ho YK, Brown MS, Bilheimer DW, Goldstein JL (1976) Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest 58:1465–1474PubMedCrossRefGoogle Scholar
  14. 14.
    Ho YK, Smith RG, Brown MS, Goldstein JL (1978) Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099–1114PubMedGoogle Scholar
  15. 15.
    Hungria VTM, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC (2004) Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemother Pharmacol 53(1):51–60CrossRefPubMedGoogle Scholar
  16. 16.
    Iribarren C, Reed DM, Yano K (1995) Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 92:2396–2403Google Scholar
  17. 17.
    Lewis GF, Lamarche B, Uffelman KD, Heatherington AC, Honig MA, Szeto LW, Barrett PH (1997) Clearance of postprandial and lipolytically modified human HDL in rabbits and rats. J Lipid Res 38(9):1771–1778PubMedGoogle Scholar
  18. 18.
    Lundberg B (1994) The solubilization of lipophilic derivates of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture. Int J Pharm 109:73–81CrossRefGoogle Scholar
  19. 19.
    Maranhão RC, Cesar TB, Pedroso MTB, Hirata MH, Mesquita CH (1993) Metabolic behavior in rats of a non-protein microemulsion resembling LDL. Lipids 28:691–696PubMedCrossRefGoogle Scholar
  20. 20.
    Maranhão RC, Garicochea B, Silva EL, Dorlhiac-Llacer P, Cadena SMS, Coelho IJC, Meneghetti JC, Pileggi FJC, Chamone DAF (1994) Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res 54:4660–4666PubMedGoogle Scholar
  21. 21.
    Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC (2002) Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol 49:487–498CrossRefPubMedGoogle Scholar
  22. 22.
    Maranhão RC, Roland IA, Toffoletto O, Ramires JA, Goncalves RP, Mesquita CH, Pileggi F (1997) Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors. Lipids 32:627–633PubMedCrossRefGoogle Scholar
  23. 23.
    Marchese SRM, Mesquita CH, Cunha IIL (1998) Anacomp program application to calculate 137 C transfer rates in marine organisms and dose in man. J Radioan Nucl Chem 232:233–236CrossRefGoogle Scholar
  24. 24.
    Matthews CME (1957) The theory of tracer experiments with l31I-labeled plasma proteins. Phys Med Biol 2:36–41CrossRefPubMedGoogle Scholar
  25. 25.
    Muller CP, Trilling B, Steinke B (1992) The prognostic significance of total serum cholesterol in patients with Hodgkin’s disease. Cancer 69(4):1042–1046PubMedCrossRefGoogle Scholar
  26. 26.
    Pandolfino J, Hakimian D, Rademaker AW, Tallman MS (1997) Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. Am J Hematol 55:129–133CrossRefPubMedGoogle Scholar
  27. 27.
    Pinto LB, Wajngarten M, Silva EL, Vinagre CC, Maranhão RC (2001) Plasma kinetic of a cholesterol-rich emulsion in young, middle-aged, and elderly subjects. Lipids 36:1307–1311PubMedCrossRefGoogle Scholar
  28. 28.
    Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhão RC (2002) Use a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel. J Pharm Pharmacol 54:765–772CrossRefPubMedGoogle Scholar
  29. 29.
    Santos R, Chacra A, Vinagre C, Morikawa A, Silva V, Ficker E, Martinez T, Maranhão R (2003) Plasma kinetics of a cholesterol-rich emulsion that binds to LDL receptors in familial hipercholesterolemia: effects of statins. Atherosclerosis 4(Suppl):241Google Scholar
  30. 30.
    Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhao RC (2003) Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. J Lipid Res 44:464–469CrossRefPubMedGoogle Scholar
  31. 31.
    Sowby FS Radiation protection. In: Limits for intakes of radionuclides by workers. IRCP publication 30. Part I. Pergamon, OxfordGoogle Scholar
  32. 32.
    Spiegel RJ, Schaefer EJ, Magrath IT, Edwards BK (1982) Plasma lipid alterations in leukemia and lymphoma. Am J Med 72:775–782CrossRefPubMedGoogle Scholar
  33. 33.
    Teixeira RS, Curi R, Maranhão RC (2004) Effects on walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE). J Pharm Pharmacol 56(7):909–914CrossRefPubMedGoogle Scholar
  34. 34.
    Valduga CJ, Fernandes DC, Lo Prete AC, Azevedo CHM, Rodrigues DG, Maranhão RC (2003) Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol 55(12):1615–1622CrossRefPubMedGoogle Scholar
  35. 35.
    Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK, Lad PM (1994) Flow cytometric evaluation of LDL receptors using DiI-LDL uptake and its application to B and T lymphocytic cell lines. J Immunol Methods 177(1–2):55–67CrossRefPubMedGoogle Scholar
  36. 36.
    Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK, Lad PM (1995) Regulation of low-density lipoprotein receptors and assessment of their functional role in Burkitt’s lymphoma cells. Biochim Biophys Acta 1257(1):47–57PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Ketlin V. Pinheiro
    • 1
  • Vania T. M. Hungria
    • 2
  • Elisabeth S. Ficker
    • 1
  • Claudete J. Valduga
    • 1
  • Carlos H. Mesquita
    • 3
  • Raul C. Maranhão
    • 1
    • 3
    • 3
  1. 1.Lipid Metabolism Laboratory, Heart Institute (InCor)University of São Paulo Medical School HospitalSão PauloBrazil
  2. 2.Hematology and Hemotherapy SectionSanta Casa Medical SchoolSão PauloBrazil
  3. 3.Faculty of Pharmaceutical SciencesUniversity of São PauloSão PauloBrazil

Personalised recommendations